Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 billion Japanese yen ($3.3 billion) to acquire Mitsubishi Tanabe Pharma in a carve-out transaction from its parent Mitsubishi Chemical Group.
Bain Capital has a 39% stake in the company, according to LSEG data. Shares of Surgery Partners rose 17% in early trading.
Bain Capital kicked off the bidding war for MLC-owner Insignia Financial and has certainly pulled out all the stops to ...
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.
Here is Iona Bain's expert financial advice... This video can not be played How new rules may make it harder for local banks ...
A study by University of Montana students analyzes the impact of wildfires on high-elevation lakes.The study, lead by Ph.D.
Investment to accelerate Milacron’s growth and strengthen its position as a global leader in highly engineered plastic processing solutions. Milacron’s comprehensive suite of equipment offerings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback